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INTRODUCTION 
Cancer is currently the second 
leading cause of death in Costa Rica, 
with malignant tumors of the stomach, 
uterus, lung, and breast (in that order) 
causing the most deaths. In terms of inci-
dence, cancers of the uterine cervix, 
breast, and skin arc the commonest 
among the female population. Each year 
more than 600 new cases of cervical can-
cer are diagnosed, and about 100 deaths 
from this cause are reported. The corre-
sponding figures for breast cancer are 
over 200 diagnoses and around 70 
deaths. 
This article seeks to describe 
patterns of breast and cervical cancer in-
cidence and mortality in Costa Rica. For 
this purpose mortality is defined as the 
number of deaths in a given year (or the 
"N, 
▪ average number per year over a longer 
period) divided by the population at the 
middle of the year or other period in- 
- volved. Incidence is defined as the num- 
▪ ber of new cases detected each year (or 
' This article was also published in Spanish in the Bole fin 
de la Oficrna Sanitaria Panamericana, vol. 102, no. 5. 
1987 (pp. 483-494). 
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the average number detected per year 
over a longer period) divided by the pop-
ulation at the middle of the year or pe-
riod involved. In both cases the popula-
tion in question is the female population 
20 years of age and over, since breast and 
uterine cancers very rarely occur in youn-
ger women. 
MATERIALS AND 
METHODS 
The data on deaths employed 
here were obtained from Vital Statistics 
published by Costa Rica's General Cen-
sus and Statistics Bureau (1). These data, 
especially those regarding cancer deaths, 
are considered reliable. 
The mortality data for cancer 
of the uterus include cancers at all uter-
ine sites. Many of these were recorded as 
being "other malignant tumors of the 
uterus, part unspecified," most of which 
are presumed to have been cancers of the 
cervix. In 1960 half of the deaths as-
cribed to uterine cancer were caused by 
tumors whose sites were not specified, 
whereas by 1983 this proportion had 
dropped to 20%. It can be assumed that 
the greater part (more than 90%) of all 
deaths from cancers of the uterus are 
caused by cervical cancers. 
The data on cancer incidence 
were obtained from the National Regis-
ter of Tumors established by Costa Rica's 
Ministry of Health in 1977. From 1980 
onward the coverage provided by this 
register is considered good. The data in it 
are derived from the following sources: 
• a tumor information sheet 
that is completed for every hospital dis-
charge involving cancer and that may 
also be used for cancer-related outpatient 
consultations; 
• biopsy reports; 
• autopsy reports; 
• death certificates. 
The data are processed manu-
ally. The authors observed that the Na-
tional Register of Tumors was adminis-
tered carefully and responsibly, that 
there were no backlogs, and that man-
agement of the paperwork involved was 
properly organized and standardized. 
They also found good cooperation to ex-
ist with regard to the transmittal of infor-
mation by hospitals and pathologists. 
With a view to evaluating the 
completeness of the National Register of 
Tumors data, 133 hospital discharges of 
patients with breast, uterine, and ovar-
ian cancers were given a detailed exami-
nation. These discharges, which gave the 
full name of each patient, constituted all 
the discharges involving these cancers in 
the first quarter of 1983. The data were 
obtained from the computerized archives 
of the Costa Rican Social Security System 
with the assistance of Dr. Oscar Fallas. 
Only three discharges were found to be  
missing from the National Register of 
Tumors, indicating only slight underre-
cording (on the order of 2%). 
While this degree of com-
pleteness appears satisfactory, it should 
also be noted that the register was found 
to have certain shortcomings. For one 
thing, the date of the first diagnosis was 
not clearly stated. As a result, new cases 
reported to the register were considered 
to date from the time when the informa-
tion about them reached the register, 
rather than from the time they were first 
diagnosed. Hence, about 10% of the 
new cases recorded for any given year 
were in fact diagnosed in the previous 
year. 
Also, some duplications were 
found. Since the information included 
in the register came from various sources, 
and since names were sometimes impre-
cisely recorded, at times the same case 
appeared as two different cases. Out of a 
total of 1,100 new cases recorded in 
1982-1983, 15 such duplications were 
observed. 
RESULTS 
Mortality 
As Table 1 shows, in each year 
from 1980 through 1984 some 12 to 16 
of every 100,000 Costa Rican women 
over age 20 died of breast cancer, and 
some 17 or 18 died of uterine cancer. 
Breast cancer mortality appears to have 
been slightly lower before 1980, while 
uterine cancer mortality was considerably 
higher (sec Figure 1). 
There is insufficient evidence 
to determine whether the slight upward 
trend observed in the breast cancer mor-
tality figures indicates a genuine increase 
or merely reflects improved statistics. If 
the upward trend is real, that would sug- 251 
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TABLE 1. Mortality from breast and cervical cancer in Costa Rice per 100,000 women ever 19 years of age,' 
1960-1984. 
Type 01 cancer 
and age group 
(In years) 1960° 1965° 1970° 1975° 1980 1981 1982 1983 1984 
Breast cancer: 
20-29 0 1 0 0 1 1 0 1 0 
30-39 6 5 4 4 0 4 5 5 9 
40-49 11 12 10 13 12 15 14 12 19 
50-59 19 23 24 22 30 18 21 29 31 
60-69 35 17 31 38 40 51 52 43 46 
z 70 51 74 47 55 83 58 66 70 96 
Total (z 20 years) 10 11 10 11 12 12 12 13 16 
Uterine cancer: 
20-29 3 4 1 2 1 1 0 1 0 
30-39 16 16 10 11 7 8 5 1 4 
40-49 49 45 25 20 20 23 19 14 20 
50-59 71 74 54 32 29 25 33 40 35 
60-69 93 97 59 65 51 44 61 52 46 
z 70 148 141 146 130 98 120 94 130 140 
Total (z 20 years) 35 36 25 21 17 17 17 17 18 
Source: General Census and Statistics Directorate. Vat Statistics (1J. 
During the period studied the age composition of the female population over 19 remained nearly =slant so there was no need ID standard- 
ize the data for this variable. 
° Moving three-year averages .  
FIGURE 1. Breast and uterine cancer mortality in Costa Rica, 1960-1983. 
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gest a sharp rise in the incidence of breast 
cancer, because medical care improve-
ments have reduced the lethality of this 
disease. Such an increase in the incidence 
of breast cancer, which is plausible, could 
be associated with socioeconomic im-
provements and reduced fertility, factors 
known to increase the risk of contracting 
the disease. Indications of slight upward 
trends in the incidence of breast cancer 
have also been found in other countries 
(2). Table 1 shows that the apparent in-
creases in Costa Rica have occurred 
among older women, especially those 
over age 60.4 
Figure 1 shows a marked 
downward trend in uterine cancer mor-
tality beginning in the second half of the 
1960s. Overall, mortality fell from 36 to 
17 per 100,000 between 1965 and 1980, 
a considerable reduction that parallels re-
ductions observed in certain other coun-
tries including the United States (3). The 
reductions in Costa Rica have occurred 
among all the age groups studied, but 
have been least pronounced in the oldest 
women. That is, as indicated in Table 1, 
the reduction among women over 70 was 
around 30%, while among groups under 
60 the reduction exceeded 55% . The fac-
tors responsible for this trend are most 
likely socioeconomic improvements 
within the country and actions taken to 
detect the disease early. 
Studies made in other coun-
tries have shown uterine cancer to be a 
"disease of the poor" (3). It is distinctly 
more common among groups having less 
education, receiving lower incomes, and 
4 An analysis of breast and uterine cancer mortality by 
cohorts (not shown) was carried out. However, no statis-
tically significant differences between generations were 
found in the available data. In the case of uterine can-
cer, this analysis clearly showed that most of the down-
ward trend was time-related rather than generation-
related, because mortality fell markedly in all cohorts 
over the study period. 
residing in less-developed regions or 
countries. Therefore, there is good rea-
son to suppose that the considerable eco-
nomic and social advances achieved by 
Costa Rica over the past few decades have 
reduced the risk of developing this 
cancer. 
It should also be noted that 
family planning programs begun at the 
end of the 1960s started the practice of 
taking vaginal smears from women at-
tending Social Security and Health Min-
istry health facilities. This activity dearly 
contributed to early detection of cervical 
cancer and saved many lives through 
timely treatment. The fact that the fam-
ily planning programs started around the 
time that uterine cancer mortality began 
its decline suggests a more than coinci-
dental connection. 
Incidence 
Although the National Regis-
ter of Tumors provides information 
about cancer incidence since 1977, its 
data are only considered reliable begin-
ning in 1979 and 1980. Hence, the ap-
parently increasing rates of breast cancer, 
cervical cancer in situ, and invasive cervi-
cal cancer in 1977-1980 (see Table 2) 
probably reflect improvements in the 
register's coverage during its first few 
years of operation rather than actual in-
creases in the diseases studied. 
Between 1979 and 1985, ac-
cording to the register, roughly 38 
women per 100,000 over age 20 devel-
oped breast cancer, the annual incidence 
ranging from 36 to 42 with no dear up-
ward or downward trend. In contrast, the 
incidences of both cervical cancer in situ 
and invasive cervical cancer exhibited 
marked declines in this period (see Table 
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TABLE 2. The Incidences of breast cancer, cervical cancer in situ, 
and invasive cervical cancer per 100,000 among women over 19 
years of age In Caste Rica during 1977-1985, by year. 
Year 
Breast 
cancer 
(cases per 
100,000) 
Cervical cancer Ratio of 
invasive 
to in situ 
cases 
in situ 
(cases per 
100,000) 
invasive 
(cases per 
100,000) 
1977 26.5 42.1 39.1 0.93 
1978 27.5 37.3 37.9 1.02 
1979 37.9 66.5 44.6 0.67 
1980 42.2 68.9 51.5 0.75 
1981 37.1 73.2 50.1 0.68 
1982 38.1 63.1 38.9 0.62 
1983 38.7 47.6 36.2 0.76 
1984 36.8 36.5 36.0 0.99 
1985 36.4 37.2 36.0 0.97 
Source: Ministry al Hearth of Costa Rica, National Register of Tumors. 
2). These data arc generally consistent 
with a worldwide trend downward in the 
incidence of this cancer (4). However, 
this gradual worldwide trend does not 
match the sharp drop in a relatively short 
time that is seen in the Costa Rican data. 
It is probable that the number of cases 
recorded during the first few years was ar-
tificially inflated by cases actually per-
taining to previous years. It is also likely 
that early case-detection activities di-
rected at cervical cancer slackened off 
later in the period, a circumstance that 
could account for the very large drop in 
the number of in situ cases recorded dur-
ing 1983-1985. 
The ratio of invasive to in situ 
cases showed a considerable decline in 
1979, probably as a result of more com-
plete records being obtained. This was to 
have been expected, especially with re-
gard to the larger numbers of less severe 
(in situ) cases being detected. 
When progress is made in the 
early detection of cervical cancer, the in-
cidence of in situ cases tends to increase  
and the ratio of invasive to in situ cases 
tends to diminish. Hence, the apparent 
reduction in the incidence of in situ cases 
and the increase in the ratio of invasive to 
in situ cases in 1983-1985 suggests dete-
rioration of the early detection programs. 
Incidence by age and cumulative 
risk. With regard to incidence, breast 
cancer and invasive cervical cancer both 
show an almost linear increase with age 
(see Table 3 and Figure 2). About one 
out of every thousand Costa Rican 
women 60-64 years of age was found to 
develop each of these carcinomas in a 
year. These risks are roughly twice those 
found among women 40-44 years old. 
Also, even though the specific rates of 
these two types of cancer in the 44-74 
age groups are quite similar (see Table 3), 
the rates of breast cancer arc lower 
among the younger age groups, rise 
more rapidly with age, and tend to be 
higher in the oldest age groups than the 
rates of invasive cervical cancer. 
As may also be seen in Figure 
2 and Table 3, the incidence by age of in 
situ cervical cancer follows quite a differ-
ent pattern. That is, it rises progressively 
TABLE 3. Incidences of breast cancer, in situ cervical cancer, and invasive cervical cancer (annual cases per 
100,000) among Costa Rican and U.S. women, by age group, in 1980-1983 in Costa Rica and 1973-1977 in 
the United States. 
Age group 
(in years) 
Costa Rica United States' 
Breast 
cancer 
Cervical cancer Breast 
cancer 
Cervical cancer 
in situ invasive in situ invasive 
20-24 — 24 2 1 56 3 
25-29 3 80 13 9 129 9 
30-34 9 109 28 28 131 17 
35-39 25 112 37 62 95 21 
40-44 45 106 59 114 63 22 
45-49 77 51 79 180 38 22 
50-54 89 45 83 209 25 24 
55-59 96 27 96 240 19 28 
60-64 103 30 103 262 16 28 
65-69 123 39 123 294 18 29 
70-74 132 16 132 313 13 29 
75-79 163 12 140 349 9 28 
80 199 17 133 372 5 33 
Total (z 20 years) 39 63 44 
Cumulative risk (%) 5.3% 3.3% 5.1% 12.2% 3.1% 1.5% 
Sources: Ministry of Health of Costa Rica, National Register of Tumors; and U.S. National Cancer Institute; Surveillance, Epidemiology. and 
End Result (SEER); N1H Publication No. 81-2330, Bethesda, 1981. 
' White women only. 
among younger women, reaching a max-
imum between the ages of 30 and 45. In 
this group the incidence exceeds one case 
per thousand women. Then, during the 
early 40s, the risk of developing in situ 
cervical cancer declines sharply. However, 
since in situ cancer tends to develop over 
time into invasive cancer, it is logical that 
in situ cancer should predominate in 
younger women and then become less 
significant with age as the rate of invasive 
cancer increases. 
Comparison of these data 
with U.S. data for 1973-1977 shows that 
the incidence of breast cancer was clearly 
lower in Costa Rica, while that of cervical 
cancer was higher. Specifically, the risk of 
developing breast cancer was less than 
half the U.S. figure for Costa Rican 
women of all ages. On the other hand, 
the relative risk of developing invasive 
cervical cancer rose progressively with age  
among Costa Rican women, reaching 
four to five times the risks found for 
older U.S. women of comparable ages. 
Especially because of this lat-
ter finding, it is noteworthy that the rates 
of in situ cervical cancer found in the two 
countries were quite similar. This similar-
ity suggests that Costa Rica's early detec-
tion programs were efficient and that the 
overall quality of data in the National 
Register of Tumors was good. However, 
the fact that the rates of in situ cervical 
cancer were higher in the United States 
than in Costa Rica up to around 35 years 
of age indicates that there is room for im-
provement in the Costa Rican programs. 
In addition, the observed patterns make 
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FIGURE 2. Relationships observed between patient age and cancers of the 
breast and cervix In Costa Rica (1980-1983) and the United States 
(1973-1977). 
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CERVICAL CANCER 
it reasonable to hope for substantial fu-
ture reductions in invasive cervical cancer 
rates in Costa Rica, as the women among 
whom in situ cancers are being detected 
and treated grow older. 
Combining the observed age-
specific incidences for all age groups to-
gether creates a summary index not af- 
fected by the age structure of the 
population. This is commonly referred to 
as the "cumulative risk" or "whole-life 
risk" index (4, 3). It can be interpreted as 
an estimate of the risk of developing the 
disease at any time during one's life (it 
may also be defined for a particular age 
group), assuming for theoretical pur-
poses that there are no competitive risks 
of dying from other causes. 
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The last line of Table 3 shows 
that the cumulative risk of developing 
breast cancer in Costa Rica in 1980-1983 
was a little over 5% , or less than half the 
risk in the United States in 1973-1977 
(12% ). Also, the cumulative risk of de-
veloping invasive cervical cancer in Costa 
Rica was a little over 5% , or over three 
times greater than the risk in the United 
States (L5% ), while the risk of develop-
ing in situ cervical cancer in Costa Rica 
was 3.3% , a risk similar to that found in 
the United States. Despite the fact that 
the cumulative risk of contracting this 
latter cancer in Costa Rica is less than that 
of contracting the other two, the total in-
cidence (the line above cumulative risk in 
Table 3) is higher because in situ cervical 
cancer is found most commonly among 
younger women—those in the most nu-
merous population groups. 
Figure 3 compares the cumu-
lative risk of invasive cervical cancer in  
Costa Rica to that found in other popula-
tions. Of these populations, only those 
in Brazil and Colombia were found to 
experience risks exceeding 5% . The oth-
ers (North American, European, Israeli, 
Asian, and African) experienced rates on 
the order of 1-2%. Hence, Costa Rica 
provides no exception to the rule that 
cervical cancer tends to be much more 
common in Latin America than else-
where. At the same time, this relatively 
high rate provides some assurance re-
garding the completeness of data in the 
National Register of Tumors. 
Geographic distribution. As Table 4 
shows, the observed breast cancer inci-
dence and mortality were higher in Costa 
Rica's four central provinces (San Jose, 
Alajuela, Cartago, and Heredia) and 
FIGURE 3. The cumulative risk of developing cervical cancer 
experienced by female populations in Costa Rica and other 
areas. 
Cumulative risk (%) 
2 	 4 	 6 
1 
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Sources: Costa Rican National Register of Tumors, and Cramer (3). 
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TABLE 4. Geographic distribution of bruit and cervical cancer incidence (1982-1983) 
and breast and uterine cancer mortality (1980-1983) in Costa Rica, by province. The 
rates shown are per 100,000 women over 19 years el age. 
Incidence, 1982-83 
Province 
Breast 
cancer 
Cervical cancer Mortality. 1980-83 
Breast 
cancer 
Uterine 
cancer in situ invasive 
San Jose 51 58 39 15 17 
Alajuela 36 52 27 11 19 
Cartago 34 44 28 12 18 
Neredia 44 53 30 12 14 
Guanacaste 27 76 51 11 10 
Puntarenas 14 64 46 7 22 
Limon 25 38 39 12 20 
Total 39 56 38 12.5 17 
Source: Costa Rica, Ministry of Health, National Register of Tumors: and General Census and Statistics Directorate, 
Vital Stems (1). Provincial populations were estimated by the authors on the basis of population censuses of 
1973 and 1984. 
lower in the three coastal provinces 
(Guanacaste, Puntarenas, and LimOn). 
Also, San Jose had the highest rates and 
Puntarenas the lowest. Indeed, the ob-
served incidence of breast cancer in San 
Jost was nearly four times that prevailing 
in Puntarenas, and breast cancer mortal-
ity in San Jose was over twice as high. In 
general, the geographic differences ob-
served for breast cancer are similar to 
those observed by Moya de Madrigal et 
al. (6) in a study of deaths and hospital 
discharges from 1956 to 1969. 
The causes underlying the 
high San Jose figures are uncertain. 
There could of course be artificially high 
numbers of cases and deaths recorded at 
health care centers in and around the 
capital; but the fact that this same pat-
tern is not repeated for San Jose in the 
case of uterine and other cancers suggests 
that the observed geographic differential 
is genuine. 
For proper interpretation of 
these and other findings, it should be 
noted that the four central provinces en-
joy a higher level of well-being than the 
coastal provinces. They also exhibit lower 
birth rates, greater family stability, and a 
much lower propensity for illegitimate 
births and consensual unions. 
Regarding cervical-uterine 
cancer, no clear provincial patterns 
emerged. That is, the highest incidence 
of both in situ and invasive cervical can-
cer was found in Guanacaste Province; 
but, paradoxically, this province is the 
one where recorded uterine cancer mor-
tality was lowest. Puntarenas, on the 
other hand, yielded more consistent data 
showing it to have had the second-high-
est incidence of invasive cervical cancer 
and the second-highest uterine cancer 
mortality. Limon stood out by reason of 
its low incidence of in situ cervical cancer 
and because it was the sole province with 
more invasive than in situ cases. 
It had been expected that 
these three coastal provinces (Guana-
caste, Puntarenas, and Limon) would 
show the highest cervical and uterine 
cancer incidence and mortality, since 
they contain the country's poorest popu-
lation groups—wherein women tend to 
become sexually active at a relatively 
early age and commonly have a number 
of conjugal unions. Hence, Guanacaste's 
low mortality and Limfon's low incidence 
arc noteworthy. In the case of the latter 
province, the low incidence could be ex-
plained by shortcomings of the early cer-
vical cancer detection program and by 
failure to provide full notification about 
cases of this type of cancer to the Na-
tional Register of Tumors. 
It should also be mentioned 
that the previously cited study by Moya 
de Madrigal and colleagues (6) was like-
wise unable to arrive at clear condusions 
regarding the distribution of uterine can-
cer morbidity and mortality by province. 
In that study Guanacaste Province 
showed the lowest mortality throughout 
the 1956-1969 study period. Lim6n 
Province, on the other hand, showed the 
highest rates of hospital discharges for 
uterine cancer, a finding that contrasts 
sharply with the low incidence found by 
the present study. This is one more piece 
of evidence suggesting that the National 
Register of Tumors data for this province 
arc incomplete. 
Early detection. Public health au-
thorities have sought to achieve second-
ary prevention of breast and cervical can-
cer by means of early detection 
programs. These programs arc directed 
at diagnosing the disease in the earliest 
stages of development, even before the 
appearance of symptoms. For these two 
types of cancer it is possible to set up effi-
cient, large-scale early detection pro-
grams; and, since the lesions detected in 
this way are generally small, the proba-
bility of being able to cure them by 
means of local treatment is relatively 
good. 
In Costa Rica, programs for 
early detection of cancer have concen-
trated primarily on cancers of the uterine 
cervix. Detection of initial and precan-
cerous lesions is done by means of exfoli-
ative cytology (Pap smears). The smears 
are taken at Ministry of Health and Social 
Security outpatient facilities. 
The family planning services 
offered by these two institutions since 
1968 and 1970, respectively, have greatly 
facilitated development of the program. 
More than 200,000 smears arc taken 
yearly. As shown in Table 5, the available 
data indicate that the number taken 
grew fairly steadily from 1977 through 
1986, but that the increase was slower 
than the rate of population growth, and 
so population coverage declined from 
39% in 1977 to 32% in 1986. This 
downward trend is a cause for concern, 
although it does not in any way detract 
TABLE 5. Number of Papanicelsou smears taken in 
Costa Rica and the percent coverage of the female 
population ever 19 years aid, from 1977 through 
1986. 
Year 
No. of Pap 
smears 
taken 
% coverage of 
female population 
over 19 years old 
1977 193,515 39 
1978 194,378 38 
1979 206,931 38 
1980 215,699 38 
1981 214,906 37 
1982 221,742 36 
1983 211,194 33 
1984 237,921 36 
1985 222,887 33 
1986 224,903 32 
Sources.- COM Rica, Social Securely, Wm& TacnIca Actuarial y 
de Plannfcacldn Institutional: and personal communication, Dr. 
Emilia Leon, Chief of the Wart/nerd of Chronic MUM, Costa 
Rican Ministry of Health. 
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from the past value of the early cervical 
cancer detection program. 
Coverage provided by this 
program has been especially noteworthy 
among women 25 to 44 years old, being 
substantially higher than for other 
groups (Table 6). In particular, coverage 
has been much lower among women be-
yond the fertile ages, even though these 
latter have shown the highest rates of in-
vasive cervical cancer. 
The overall percentage of 
women over 19 from whom Pap smears 
have been taken is not known, nor do we 
know the overall priority assigned to this 
examination. (The percentage of women 
covered cannot be obtained by combin-
ing the numbers covered in successive 
years, because these numbers include 
women who had smears taken in more 
than one of those years.) Preliminary 
findings of a study on contraception and 
cancer risk carried out by the Costa Rican 
TABLE 6. Papanicoliou smears taken from Costa 
Rican women belonging to different age groups In 
1983, showing the number of smears taken and the 
percent coverage provided In each group. 
Age group 
(in years) 
No. of 
smears 
taken 
Coverage 
provided 
(%) 
15-24 54,845 21 
25-34 79,539 42 
35-44 41,748 36 
45-54 21,556 26 
55-64 8,867 16 
65 4,639 9 
Sourut.' The flints shown are estimates baSed on the data in Ta-
ble 5 and data provided by the National Morbidity Survey (External 
Consultation of 1983, personal communication by Dr_ Herman 
vary's). 
Demographic Association (Asociacion 
Demografica Costarricense) show that as 
of 1984-1985 some 26% of all Costa Ri-
can women between 25 and 59 years old 
had never had a Pap smear taken. 
Regarding breast cancer, the 
early detection programs for this prob-
lem are basically educational and in-
formative in nature, seeking mainly to 
encourage self-examination. Their scope 
is more difficult to measure. However, 
preliminary findings of the aforemen-
tioned study indicate that no more than 
16% of Costa Rican women make a prac-
tice of frequently examining their 
breasts, and that 58% have never done 
so. Recent establishment of the Society 
of Mastectomized Women and the Na-
tional Cancer Council in Costa Rica gives 
grounds for hoping that major programs 
for early detection of breast cancer will be 
implemented in the future. 
CONCLUDING REMARKS 
In dosing, it is appropriate to 
underscore the epidemiologic impor-
tance of the National Register of Tumors. 
Despite the fact that this register was not 
set up until relatively recently, it has 
proven to be a reasonably reliable source 
of very valuable data. 
Overall, trends observed in 
other countries, including the United 
States, lead to an expectation that breast 
cancer incidence and mortality will in-
crease in Costa Rica. It is also probable 
that the incidence of in situ cervical can-
cer among young women will rise as a 
result of further improvements in early 
detection programs. On the other hand, 
it is to be expected that the role of inva-
sive cervical cancer will decline, particu-
larly with the aging of the cohorts of 
women who have participated in early 
detection programs in recent years. 
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SUMMARY 
This article seeks to describe 
patterns of breast and uterine cancer 
morbidity and mortality in Costa Rica by 
examining and analyzing available data 
from several sources. 
Regarding mortality, these 
data suggest a slight rise in breast cancer 
mortality between 1960 and 1984, 
mostly in women over 60, and also docu-
ment a sharp drop in uterine cancer mor-
tality. The latter decline (from 35 cases 
per 100,000 to 18) paralleled similar de-
clines in certain other countries and was 
sharpest in younger women. The factors 
most likely responsible for this down-
ward trend were improvement of so-
cioeconomic conditions and implemen-
tation of a national family planning pro-
gram that routinely took Pap smears in 
order to detect the disease early. 
Regarding morbidity, data 
from 1979 through 1985 showed no clear 
upward or downward trend for breast 
cancer but did show a marked drop in 
the rates of both in situ and invasive cer-
vical cancer. These changes could be 
accounted for by variations in the pace 
of case-detection and case-recording 
activities. 
Regarding the ages of affected 
subjects, morbidity data for 1980-1983 
show an almost linear increase with in-
creasing age for both breast and cervical 
cancer, together with high rates of in situ 
cervical cancer among women of child- 
bearing age. (Since in situ cervical cancer 
tends to develop into invasive cancer over 
time, it is logical that the former should 
predominate in younger women and 
then become less significant with age as 
the rate of invasive cervical cancer in-
creases.) 
Comparison of these 1980-
1983 data with U.S. data for 1973-1977 
shows the rate of breast cancer to be 
lower in Costa Rica and that of cervical 
cancer to be higher. It also suggests that 
Costa Rica's early cervical cancer detec-
tion program was reasonably efficient in 
these years but could be improved, and 
that further declines in the rate of inva-
sive cervical cancer can be expected. 
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